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http:WHAT THIS PAPER ADDS
This single-center study, evaluating long term follow-up (mean 56  21 months) after endovascular popliteal
artery aneurysm repair (EVPAR), demonstrates that this procedure is durable and guarantees effective aneurysm
sac shrinkage over time. However, based on these results, when selecting the patient for endovascular repair,
the length of coverage and the need for close surveillance especially during the ﬁrst year of follow-up should be
carefully evaluated.Objectives: The aim was to evaluate long-term outcomes and sac volume shrinkage after endovascular popliteal
artery aneurysm repair (EVPAR).
Methods: This study was a retrospective review of all EVPAR cases between 1999 and 2012. Sac volume
shrinkage, long-term patency, limb salvage, and survival were evaluated using KaplaneMeier estimates. The
association of anatomical and clinical characteristics with patency was evaluated using multivariate analysis.
Results: Forty-six EVPAR were carried out in 42 patients (mean age 78 years, 86% male; mean sac volume
45.5  3.5 mL). In 93% of cases (n ¼ 43) the procedure was elective, while in 7% of cases it was for rupture
(n ¼ 2) or acute thrombosis (n ¼ 1). Of the 43 patients who underwent elective repair, 58% were asymptomatic
and 42% symptomatic (14 claudication, 3 rest pain, and 1 compression symptoms). Technical success was 98%.
Mean duration of follow-up was 56  21 months. Primary patency at 1, 3, and 5 years was 82% (SE 2), 79% (SE 4),
and 76% (SE 4), while secondary patency was 90% (SE 5), 85% (SE 4), and 82% (SE 1) respectively; at 5 years there
was 98% limb salvage and an 84% survival rate. During follow-up 11 limbs had stent graft failure: six required
conversion, one underwent amputation, and four continued with mild claudication. Of those with graft failure,
63% (7/11) occurred within the ﬁrst year of follow-up. The mean aneurysm sac volume shrinkage between
preoperative and 5-year post-procedure measurement was signiﬁcant (45.5  3.5 mL vs. 23.0  5.0 mL;
p < .001). Segment coverage >20 cm was a negative predictor for patency (HR 2.76; 95% CI 0.23; p ¼ .032).
Conclusions: EVPAR provides successful aneurysm exclusion with good long-term patency, excellent limb salvage,
and survival rates. Close surveillance is nevertheless required, particularly during the ﬁrst postoperative year.
Patients requiring long segment coverage (>20 cm) may be at increased risk for failure.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Popliteal artery aneurysm (PAA) is the second most
frequent location of arterial aneurysm1; they are often
asymptomatic, but when symptoms are present, and in
patients with acute ischemia, the risk of limb loss can be as
high as 30e40%.2rresponding author. M. Piazza, Vascular and Endovascular Surgery
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, Italy.
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//dx.doi.org/10.1016/j.ejvs.2014.04.011To avoid complications, repair is recommended when the
aneurysm diameter is  20 mm; symptomatic aneurysm
should be repaired whenever possible.3
Even if surgical repair is the gold standard for treatment,4
advantages linked to a minimally invasive approach have led
to a signiﬁcant increase in the number of endovascular
popliteal artery aneurysm repairs (EVPAR) carried out not
only for elective treatment but also in selected emergent
situations such as acute thrombosis or rupture.5 Our pre-
vious experience comparing EVPAR in patients with suitable
anatomy versus open repair, conducted in the subcategory
of asymptomatic aneurysm, demonstrated similar outcomes
in terms of patency rate.6
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described,7,8 the procedure’s long-term durability has yet to
be analyzed. Nor have the long-term clinical implications of
aneurysm sac exclusion and shrinkage linked to EVPAR been
assessed. In this regard, endoleak occurrence plays a major
role; the overall incidence of endoleak ranges from 0 to
20%,9 with a signiﬁcant proportion of these classiﬁed as
type I and III secondary to stent fracture or migration10 with
ongoing aneurysm sac growth reported in 0e17% of cases.
To evaluate aneurysm sac size changes, in addition to
standard maximum diameters, aneurysm volumetric mea-
surements have been demonstrated11 to be a precise
method and were included in this study’s analysis.
The aim of this retrospective study was to report on the
long-term outcomes of EVPAR focusing on patency and limb
salvage rates, and also to identify predictors of patency.
Long-term sac volume shrinkage was analyzed to assess
durability and efﬁcacy of EVPAR in aneurysmal exclusion.MATERIALS AND METHODS
Patients
A retrospective review of all patients admitted to the
Vascular and Endovascular Surgery Clinic of Padova who
underwent EVPAR between January 1999 and December
2012 was carried out. Demographic information, preoper-
ative characteristics, perioperative outcomes, and follow-up
data including all medical records and invasive and non-
invasive diagnostic procedures were reviewed.Inclusion and exclusion criteriaInclusion criteria
1. All symptomatic and asymptomatic PAA with a diameter
2 cm on the computed tomography (CT) angiogram or
symptomatic patients only with an aneurysm with a
maximum diameter > 50% larger than the adjacent
normal artery in the same patient measured by
ultrasound12;
2. at least one patent native tibial vessel or a distal run-off
score of <8 according to the Society for Vascular
Surgery/International Society for Cardiovascular Surgery
(SVS/ISCVS)13;
3. a proximal and distal landing zone with a length of
>1 cm;
4. both elective and urgent EVPAR were included as well as
urgent cases previously treated with thrombolysis.Exclusion criteria
1. age <50 years old;
2. a history of thrombophilia;
3. contraindication to antiplatelet, anticoagulant, or
thrombolytic therapy;
4. superﬁcial femoral artery aneurysm or anastomotic
pseudoaneurysm.At the authors’ institution, the ﬁrst-line therapy for
popliteal aneurysm was open repair; however, if the above
described anatomical criteria were satisﬁed, EVPAR was also
considered based on patient presenting symptoms, co-
morbidity, and lifestyle. With this approach, endovascular
treatment was performed in 35% of patients presenting for
PAA repair, and 64.8% (n ¼ 85) underwent open repair.Treatment and deﬁnitions
The clinical presentation of elective cases was classiﬁed as
asymptomatic, as associated with claudication (or anklee
brachial index, ABI, <0.7) or with rest pain. The Trans-
Atlantic Inter-Society Consensus Document (TASC) classiﬁ-
cation14 was used to evaluate the extent of femoro-
popliteal occlusive disease. The run-off at tibial level and
the number of patent vessels were classiﬁed according to
the SVS/ISCVS, where 1 is optimal run-off and 10 indicates
absent run-off.13
Aneurysm sac volume was calculated on 1 mm CT
angiogram slices using Osirix Pro 4.0 software (Fig. 1(A and
B)). The percentages of sac thrombus volume were calcu-
lated from the difference between the external wall and
luminal volumes. To identify modiﬁcations of aneurysm
volumes and to ensure homogeneous measurements, the
calculation was performed, from the beginning to the end
of the dilatation and not considering the proximal or distal
landing zone. For three-dimensional volume changes, 5% or
more was considered signiﬁcant following SVS standards.15
The distal landing zone site in the below-the-knee
popliteal artery was classiﬁed into four groups based on
the distance (length calculated in centimeters) from the end
of the endograft to the take-off of the anterior tibial artery;
two cases characterized by its anomalous origin were not
included in the multivariate analysis.
Technical success was deﬁned as complete exclusion of
the aneurysm with preservation of the distal run-off
immediately after balloon dilatation of the stent graft.
The mean follow-up was 56  21 months (range 6e166
months); three patients were lost to follow-up. All patients
underwent a duplex ultrasound scan (DUS) and ABI mea-
surement the day before discharge. Follow-up appoint-
ments included a complete physical examination, a DUS and
ABI measurements at 1, 6, and 12 months during the ﬁrst
year and annually thereafter. All patients underwent angio-
CT scans with early and delayed phase and plain radiograph
of the knee joint with forced leg ﬂexion (>120) to evaluate
patency, stent skeleton integrity, ﬂexibility, and sac volume
once a year.
Long-term patency and limb salvage were determined in
concordance with the SVS/ISCVS guidelines.13 Notice of
death was veriﬁed using the Padova Hospital Registry
database.
The overall sac volume shrinkage during follow-up was
evaluated as the mean of values; data from three patients
(2 rupture, 1 large symptomatic aneurysm) with huge
popliteal aneurysm sacs were not included in this analysis
because of aneurysm volumes >120 mL above the largest
Figure 1. (A) Axial cut computed tomography angiogram showing region of the interest (ROI) to be analyzed for sac volume and thrombus
volume determinations. (B) Volumes were calculated in milliliters.
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volume calculation from CT angiogram axial cuts was not
reliable because of the extremely irregular shape of the sac
and poorly deﬁned margin between sac, contrast extrava-
sation areas, and adjacent tissues. However, the efﬁcacy of
the exclusion was calculated for all 46 aneurysms as the
time needed for 50% sac shrinkage during the follow-up in
four groups stratiﬁed on the basis of preoperative mean
volume (<30 mL; 30e60 mL; 60e90 mL; >90 mL).
Technical, anatomic, and clinical features were analyzed
separately and combined in a multivariate analysis to
determine any association with long-term primary patency;
furthermore, endoleak and/or thrombus volume percent-
ages were analyzed to determine any association with sac
shrinkage.
The operative technique has already been described in a
previous study16 where 15 elective limbs from the present
43 were analyzed. Brieﬂy, the stent length and diameter
were measured on the preoperative CT angiogram and used
to calculate a 10% oversizing. The coverage length was
conﬁrmed at the intraoperative angiogram, and landing
distally at the level of the knee joint was always avoided. If
multiple stent grafts were required to seal the PAA, the
endografts were made to overlap by at least 1.5 cm. The
endograft was deployed in the standard fashion with
antegrade access from the common femoral artery. A post-
procedural angiogram in lateral projection with a knee
ﬂexion >120 was always performed to conﬁrm regular
ﬂexibility of the endograft and no signs of kinking or
endoleak.
From 1999 to 2003, Hemobahn endograft (W. L. Gore &
Associates, Inc. Flagstaff, AZ, USA) were used, from 2004 to
2009 standard Viabahn, and from 2010 to date Heparin
Bonded-Viabahn stent grafts.
Oral double antiplatelet therapy with aspirin (100 mg
daily) plus clopidogrel (75 mg daily) was prescribed for 1month and thereafter patients were prescribed aspirin
alone indeﬁnitely (100 mg daily).Statistical analysis
The mean and standard deviation of sac volume, thrombus
volumes, and diameters before and after surgery were
compared using a two-sample t test. The KaplaneMeier life-
table method was used to calculate patency and survival.
The predictive value of the different variables was assessed
using the multivariate Cox proportional hazards model. A p
value <.05 was considered statistically signiﬁcant.
RESULTS
Forty-two patients underwent EVPAR; four of these were
bilateral, so a total of 46 limbs were treated; preoperative
demographics and cardiovascular risk factor are outlined in
Table 1.
93% (n ¼ 43) were elective and 7% (n ¼ 3) were urgent.
Within the elective group, 58% (n ¼ 25) were asymp-
tomatic and 42% (n ¼ 18) were symptomatic (claudication
in 33%, rest pain in 7%, and popliteal fossa compression
symptoms in 2% of cases). In ﬁve cases, the claudication
was due to atherosclerosis at other sites, in seven cases to
distal embolization in the tibial vessels, and in two cases to
a combination of the two; in three cases, rest pain was due
to severe distal embolization.
In the three cases undergoing urgent repair, two were
treated for frank rupture, and the other was a high-risk
surgical patient with acute ischemia linked to sudden
aneurysm thrombosis.
The mean maximum preoperative aneurysm sac diameter
was 3.3  0.78 cm, while the mean aneurysm sac volume
was 45.5  3.5 mL with a range from 27 mL to 135 mL;
other preoperative anatomic characteristics are outlined in
Table 2.
Table 2. Clinical presentation and anatomical preoperative
features of 46 limbs that underwent endovascular popliteal
artery aneurysm repair.
Variable Number of
limbs (n ¼ 46)
%/range
Elective repair 43 93
Asymptomatic 25 58
Symptomatic 18 42
Claudication (ABI < 0.7) 14 33
Rest pain 3 7
Blue toe syndromea 1 2
Popliteal compression 1 2
Urgent repair 3 7
Frank rupture 2 5
Acute thrombosisb 1 2
Mean aneurysm
maximum diameter (cm)
3.3  0.78 2.0e5.7
Mean aneurysm sac
volume (cm3)
45.5  3.5 27e135
Percentage of thrombus volume
0e25% 13 28
26e50% 24 53
51e75% 7 15
>75% 2 4
TASC fem-pop Bb 8 17.5
TASC fem-pop C-D 3 6.5
Distal run-off
No. patent vesselsc 1 2
1 tibial vessel 2 4
2 tibial vessels 29 63
3 tibial vessels 14 31
SVS/ISCVS run-off score
1e3 13 28
4e7 30 66
8e10 3 6
ABI ¼ ankleebrachial index; TASC ¼ Trans-Atlantic Inter Society
Consensus; SVS/ISCVS ¼ Society for Vascular Surgery/
International Society for Cardiovascular Surgery.
a In association with rest pain.
b Intended as not signiﬁcant stenosis of the femoro-popliteal tract
(not requiring treatment).
c Patient underwent thrombolytic therapy.
Table 1. Demographics, clinical data and history of aneurysmal
disease of 42 patients who underwent endovascular popliteal
artery aneurysm repair.
Demographics Number of patients
(n ¼ 42)
%/range
Age, mean SD (yr) 78.1  11 61e89
Male gender 36 86
Clinical data
BMI, mean  SD (kg/m2) 27.9  4.7 21e32
Hypertensiona 24 58
Hyperlipidemiab 20 46
Diabetesc 6 14
Smokingd 27 64
CADe 17 39
CRI (Cr > 1.5 mg/dL) 9 21
Dialysis 1 2
COPDf 6 14
Aneurysmal arterial disease
Familial history 4 9
Other associated
aneurysmal disease
8 19
Previous AAA repair 6 14
Bilateral PAA 15 36
SD ¼ standard deviation; BMI ¼ body mass index; CAD ¼ coronary
artery disease; COPD ¼ chronic obstructive pulmonary disease;
CRI ¼ chronic renal insufﬁciency; AAA ¼ abdominal aortic
aneurysm; PAA ¼ popliteal artery aneurysm.
a Patients taking at least one antihypertensive drug.
b Patients with documented diagnosis or who were being treated
for elevated plasma lipids or both.
c Deﬁned as the need for speciﬁc drugs to maintain metabolic
control.
d Current smokers and those with a history of smoking within 1
year.
e deﬁned as history of myocardial infarction, angina or electro-
cardiographic signs of myocardial ischemia.
f Deﬁned as forced expiratory volume in 1 s (FEV1) < 1 or FEV1/
FVC (forced vital capacity) < 75.
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tribution are outlined in Table 3.
There was a 98% technical success rate; in one case there
was infolding after deployment of the ﬁrst endograft
component requiring direct conversion to open repair. In six
of 15 cases in whom the covered length was>20 cm and the
distal landing zone was in the middle of the below-knee
popliteal artery, the ﬁnal intraoperative angiogram with
knee ﬂexion showed kinking just after the end of the stent
graft, a problem that was resolved in all cases with a graft
extension to within 1 cm of the anterior tibial artery take-off.
No perioperative deaths were reported. There was one early
occlusion in the elective group that was treated successfully
after thrombolysis with a tibial PTA. At 30 days within the
elective group there was a 95% overall primary patency rate,
a 98% secondary patency rate, and 100% limb salvage rate.
Therewas a high number of early adverse events in the group
treated as an emergency (1/3 major amputation and 1/3
secondary surgical procedure within the ﬁrst 30 days).
The KaplaneMeier curves for primary patency at 1, 3,
and 5 years within the 43 elective EVPAR was 82% (SE 2),79% (SE 4), and 76% (SE 4), while secondary patency was
90% (SE 5), 85% (SE 4), and 82% (SE 1) respectively (Fig. 2).
The long-term overall survival rate was 84% (SE 4), while
limb salvage was 98% (SE 2). Two patients were identiﬁed
and treated before occlusion during the follow-up period:
one was asymptomatic who developed a >70% stenosis in
the distal landing zone discovered during a DUS examina-
tion. The patient was ﬁrst treated with PTA and then con-
verted to open repair 40 days later, because of recurrent
stenosis. The other was asymptomatic with ongoing evolu-
tion of tibial atherosclerotic disease identiﬁed at follow-up
because the distal tibial pulses were absent. The patient
was treated successfully by PTA. A stent fracture without
loss of patency was found in one case (2%) on plain
radiograph of the knee joint after 2 years follow-up; it was
repaired with an additional interposition stent-graft. The
total number of limbs with stent graft failure during follow-
Table 4. Final multiple Cox proportional hazards model for clinical,
anatomic and technical characteristics in relation to primary
patency and sac shrinkage of 43 elective endovascular popliteal
artery aneurysm repair.
Variable for primary patency HR 95% CI Ratio limit p
Clinical
Claudication .453 .213 1.951 .640
Rest pain 2.1 .397 8.477 .847
Thrombosis e e e .251
Urgent repair .937 .106 1.349 .734
Anatomical
Vessels runoff (SVS/ISCVS) e e e .387
Table 3. Intraoperative technical characteristics of 46 limbs that
underwent endovascular popliteal artery aneurysm repair.
Variable Number of
limbs (n ¼ 46)
%/range
Type of stent used
Hemobahn 15 33
Viabahn 24 52
Viabahn þ Advanta 1 2
Heparin bonded Viabahn 6 13
Mean number of stent for limb 1.9  0.5 1e4
aStent diameter  7 mm 13 29
aStent diameter 8 mm 16 35
aStent diameter 9 mm 6 13
aStent diameter  10 mm. 11 23
Covering length extension
<20 cm 31 67
>20 cm 15 33
Distal landing zone site BKPA
<1.0 cm from ATA 6 13
1.0 to 2.0 cm from ATA 15 33
2.0 to 3.0 cm from ATA 12 26
3.0 to 4.0 cm from ATA 11 24
Not classiﬁedb 2 4
Associated tibial vessel PTA 2 4
Associated SFA treatment 3 6.5
Thrombolysis 1 2
BKPA ¼ below the knee popliteal artery; ATA ¼ anterior tibial
artery; PTA ¼ percutaneous transluminal angioplasty;
SFA ¼ superﬁcial femoral artery.
a Intended as the mean value of stents diameter used for each
limb.
b Anomalous origin of the ATA.
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with critical limb ischemia, and ﬁve with acute ischemia. Six
(55%) of these cases required conversion to open repair,
one (9%) underwent amputation, and four (36%) continued
with mild claudication. Interestingly, the vast majority of
these failures occurred within the ﬁrst 12 months of EVPAR
(7 out of 11 limbs; 63%) with a reduction in primary patency
to 82%. The overall “reintervention-free survival” within theFigure 2. Long-term primary, primary assisted and secondary
patency in 43 elective endovascular popliteal artery aneurysm
repairs.elective group was 70% at 5 years. Although it was not the
intention of this study to make comparisons between open
repair and EVPAR procedures, the primary patency associ-
ated with the two techniques was compared and no sta-
tistically signiﬁcant differences at 5-year follow-up were
found ( 83% vs. 76% respectively; p ¼ .65). The multivariate
analysis for patency after EVPAR (Table 4) showed that the
only negative predictors for improved patency was a
covered artery length > 20 cm (HR 2.7; 95% CI 0.2; ratio
limit of 8.2; p¼ .032); distal landing zone site was not found
to be a negative predictor of patency (p ¼ .566). The type of
endograft used did not appear to inﬂuence primary patency
(p ¼ .765, p ¼ .832 respectively). Other aspects such as
stent diameter, and aneurysm sac size (diameter and vol-
ume) did not appear to be related to long-term primary
patency. Overall, aneurysm sac volume shrank from
45.5  3.5 mL to 23.0  5.0 mL during follow-up (Fig. 3(A));
the shrinkage was signiﬁcant (p < .001) with a
25.5  5.4 mL (95% CI 18.14e22.85) difference between
the means. There was one case in which sac enlargement
was secondary to a type I endoleak (2.17%) and in eight
cases there was no shrinkage over time (17.4%).
Analysis of the shrinkage rate stratiﬁed by preoperative
aneurysm sac volume is described in Fig. 3(B). In one of the
two cases of rupture due to large PAA, compression
symptoms persisted after EVPAR was carried out, evenVessels runoff (n. of
patent tibial)
e e e .955
TASC C-D fem pop .843 .254 2.764 .406
Technical
DLZ from ATA e e e .566
CL > 20 cm 2.765 .235 8.221 .032a
Associated PTAb e e e .222
Viabahn/heparin bonded e e e .765
Hemobahn .876 .651 1.943 .832
Stent fracture .730 .603 3.081 .920
Variable for sac shrinkage
Endoleak (I and II) e e e .877
Thrombus volume (%) e e e .643
HR ¼ hazard ratio; CI ¼ conﬁdence interval; DLZ ¼ distal landing
zone; CL ¼ covering length; TASC ¼ Trans-Atlantic Inter Society
Consensus; ATA ¼ anterior tibial artery; PTA ¼ percutaneous
transluminal angioplasty.
a Statistically signiﬁcant.
b Intended as PTA of the tibial vessels.
Figure 3. (A) Overall mean sac volume shrinkage during follow-up in 43 elective cases of endovascular popliteal artery aneurysm repair. (B)
50% sac volume shrinkage during the follow-up; the aneurysms were stratiﬁed in four groups according to volume size at presentation.
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angiogram; surgical sac decompression was performed 4
days later.
There were two endoleaks (4%): one type II and one type
I. The type II endoleak resolved spontaneously within 6
months of surgery; the type I endoleak, presenting 18
months after EVPAR due to a proximal downward stent
dislodgement, was treated with a proximal extension of the
endograft. Neither endoleak affected the overall sac volume
shrinkage rate; the percentage of thrombus volume in the
aneurysm sac was not correlated with the overall sac
shrinkage or with the percentage sac volume reduction.DISCUSSION
The ﬁrst EVPAR procedure was described in 1994 by Marin
et al.,17 who used a polytetraﬂuoroethylene (PTFE) graft
mounted on a Palmaz stent (Cordis, Miami Lakes, FL, USA).
Galiñanes et al.18 recently reported that in the United
States Medicare population, EVPAR rose signiﬁcantly be-
tween 2005 and 2007, from 11.7% to 23.6% (p < .0001).
Overall primary and secondary patency reported for elective
EVPAR cases has improved according to recent studies,
reaching 80% and 90% at 1year and 77% and 87% at 2 year
of follow-up19; no signiﬁcant differences in patency were
found for the elective cases studied between the ﬁrst and
second generation endografts (p ¼ .765, p ¼ .832,
respectively).
Recent patency rates of EVPAR, seem similar to those
obtained with open repair still regarded to be the gold
standard of treatment; results extracted from the Swedish
Vascular Registry in 2007,20 report a 1-year primary patency
of 90% and 72% using venous and prosthetic grafts
respectively.
Mid-term patency for EVPAR at 3 year follow-up have
been reported by several studies; the tabular review by
Tsilimparis et al.10 reported 87% average (range 67e100%)
3 year primary assisted patency and 85% (range 82e100%)
secondary patency. Reporting in 2010 on a small sample of
15 limbs, Jung et al.21 reported primary patency of 84.6%
after 54 months. Pulli et al.,8 in a multicentre study of 134EVPAR patients, reported a primary patency of 73.4% (SE 4)
at 48 months follow-up and a secondary patency of 85% (SE
4). In this study, the long-term primary patency at 5 years
was 76% (SE 4), while primary assisted and secondary
patency were 79% (SE 3) and 82% (SE 1) respectively. It is
interesting that according to the KaplaneMeier analysis, the
patency curve at 1 year fell to 82%, with a subsequent
relatively slow decrease of 76% in patency during the
remaining 4 years. Sixty-three percent (7 out of 11 limbs) of
those limbs with graft failure occurred within the ﬁrst year
of the procedure. However, when comparing primary
patency at 1 year between asymptomatic and symptomatic
patients undergoing EVPAR in this series (86% vs. 80%,
respectively), the asymptomatic group had a patency rate in
line with other series reported, both with the endovascular
and the open repair approach. This result, other than
considering the difference between asymptomatic and
symptomatic presentations, raises the question whether
the early drop in patency could be related to inadequate
medical therapy, to technical error, or to inaccurate selec-
tion criteria. Double antiplatelet therapy is routinely used
after EVPAR and has been standard practice for many years.
Even if anticoagulation with warfarin may be advisable in
rare cases, there is no evidence that its routine use im-
proves patency compared with antiplatelet therapy. With
regard to technical aspects, in the multivariate model a
covering length >20 cm was found to be a negative pre-
dictor of patency (p ¼ .032). This ﬁnding could be explained
by considering that the longer the endograft coverage the
more pronounced the transmitted rigidity of the graft sys-
tem distal to the landing zone in a point as pliable as the
mid below knee popliteal artery, and this could be a cause
of kinking or friction in the arterial wall over time. In this
study with long segment coverage, if the ﬁnal angiogram
with knee ﬂexion demonstrated arterial kinking in the distal
landing zone site, an attempt was made to extend the
landing zone distally to within 1 cm of the take-off of the
anterior tibial artery where the artery is less ﬂexible. Doing
so resolved the problem of the kinking however landing
within 1 cm of the origin of the anterior tibial artery was
not found to be a positive predictor of patency.
European Journal of Vascular and Endovascular Surgery Volume 48 Issue 2 p. 161e168 August/2014 167Although there is no scientiﬁc evidence supporting the
usefulness of preoperative angiography with knee ﬂexion
before stent graft deployment, it is felt that this examina-
tion should be performed routinely to evaluate popliteal
artery curvature points.
While some studies have described residual patent
branches mimicking type II endoleak after open surgical
repair,22 none has evaluated the impact of EVPAR in relation
to exclusion efﬁcacy. It was important to know if the
aneurysm sac shrank after exclusion, just as an abdominal
aortic aneurysm does after repair, or if it continued to exert
compression in the limited popliteal fossa space even after
the aneurysm has been perfectly excluded.
These results clearly conﬁrm that in elective cases EVPAR
effectively excludes the aneurysm with no residual risk of
compression during follow-up. However, there was no sac
shrinkage in two ruptured aneurysms, but there was a
continued risk of compression symptoms, which occurred in
one of these cases. Surgical decompression may be required
even if the aneurysm has been successfully excluded by
EVPAR. This is an additional factor needing to be considered
when patients with large or ruptured aneurysms are being
evaluated for open or endovascular repair.
Endoleaks do not seem to affect sac shrinkage (p ¼ .877),
but there were only two in this group (one endoleak type I
and one type II) of 46 patients, and only one with sac
growth (2%); these results are similar to those outlined in
Tsilimparis et al.,10 who reported an average sac growth of
3% after EVPAR.
The single case with sac growth in this group was the
type I endoleak, that was not caused by inadequate prox-
imal sealing, but by stent dislodgment. These ﬁndings are
consistent with those of Midy et al.,9 who described six
endoleaks in a sample of 57 (10.5%) treated limbs, all type I
and III, and all as a consequence of stent malfunctioning.
This study has some limitations that are worthy of
mention. This was a retrospective, non-randomized study
with a small cohort of patients. This could also have limited
the power of the statistical analysis. Nevertheless, all pa-
tients were selected for a careful and complete follow-up
with adequate imaging, allowing robust and exhaustive
assessment of patency and sac volume shrinkage during the
long term.CONCLUSIONS
No other study has focused on the long-term patency rate
and the efﬁcacy of EVPAR in aneurysm sac exclusion.
Although further conﬁrmatory studies are needed, EVPAR
has been found to provide successful aneurysm exclusion
with good long-term patency, excellent limb salvage and
survival. Close surveillance, particularly during the ﬁrst
postoperative year is required; patients with coverage
length >20 cm seem to be at an increased risk of failure.CONFLICT OF INTEREST
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